WASHINGTON, D.C. 20549

                                    FORM 8-K

                                 CURRENT REPORT

                       Pursuant to Section 13 or 15(d) of
                       the Securities Exchange Act of 1934

                Date of Report (Date of Earliest Event Reported):
                                  June 5, 2007

                           USANA HEALTH SCIENCES, INC.

             (Exact name of registrant as specified in its charter)

                           Commission File No. 0-21116

                Utah                                         87-0500306
    (State or other jurisdiction of                 (IRS Employer Identification
            incorporation)                                    Number)

                           3838 West Parkway Boulevard
                           Salt Lake City, Utah 84120
               (Address of principal executive offices, Zip Code)

       Registrant's telephone number, including area code: (801) 954-7100

   Former name or former address, if changed since last report: Not Applicable

Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any of the
following provisions:

[  ] Written communications pursuant to Rule 425 under the Securities Act
     (17 CFR 230.425)

[  ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act
     (17 CFR 240.14a-12)

[  ] Pre-commencement communications pursuant to Rule 14d-2(b) under the
     Exchange Act (17 CFR 240.14d-2(b))

[  ] Pre-commencement communications pursuant to Rule 13e-4(c) under the
     Exchange Act (17 CFR 240.13e-4(c))

Item 8.01         Other Events

On June 5, 2007, USANA Health Sciences, Inc. issued a press release announcing
that it has signed a letter of intent to sell certain assets and inventory
associated with the third-party contract manufacturing business at its Draper,
Utah, facility, the terms of which were not disclosed. The release also
announced that the sale of this business is anticipated to be effective sometime
during the third quarter of 2007. A copy of the press release is furnished
herewith as Exhibit 99 to this Current Report on Form 8-K and is incorporated
herein by reference. The Company will also post this document on its corporate
website, www.usanahealthsciences.com, under the "investors" link.

Item 9.01         Financial Statements and Exhibits

                  (d) Exhibits

Exhibit 99        Press release issued by USANA Health Sciences, Inc. dated
                  June 5, 2007 (furnished herewith).


   Pursuant to the requirements of the Securities Exchange Act of 1934, the
   registrant has duly caused this report to be signed on its behalf by the
   undersigned hereunto duly authorized.

                                     USANA HEALTH SCIENCES, INC.

                                     By:  /s/ Gilbert A. Fuller
                                     Gilbert A. Fuller, Chief Financial Officer

Date: June 5, 2007